Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model.

[1]  R. Virmani,et al.  Extracellular Matrix Changes in Stented Human Coronary Arteries , 2004, Circulation.

[2]  T. Wakefield,et al.  Deep Vein Thrombosis Resolution Is Modulated by Monocyte CXCR2-Mediated Activity in a Mouse Model , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[3]  A. Mansfield,et al.  Venous Claudication in Iliofemoral Thrombosis: Long-term Effects on Venous Hemodynamics, Clinical Status, and Quality of Life , 2004 .

[4]  Gorav Ailawadi,et al.  Current concepts in the pathogenesis of abdominal aortic aneurysm. , 2003, Journal of vascular surgery.

[5]  Z. Galis,et al.  Expression of Matrix Metalloproteinase-9 in Endothelial Cells Is Differentially Regulated by Shear Stress , 2003, Journal of Biological Chemistry.

[6]  R. Visse,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[7]  Alberto Smith,et al.  Failure of Thrombus to Resolve in Urokinase-Type Plasminogen Activator Gene-Knockout Mice: Rescue by Normal Bone Marrow-Derived Cells , 2003, Circulation.

[8]  D. Loskutoff,et al.  Do PAI-1 and vitronectin promote or inhibit neointima formation? The exact role of the fibrinolytic system in vascular remodeling remains uncertain. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[9]  J. Michel,et al.  Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. , 2002, The American journal of pathology.

[10]  Y. Takai,et al.  Significance of plasminogen-activation system in the formation of macroscopic types and invasion in esophageal carcinoma. , 2002, Anticancer research.

[11]  D. Ginzinger.  Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. , 2002, Experimental hematology.

[12]  A. Luttun,et al.  Lack of Plasminogen Activator Inhibitor-1 Promotes Growth and Abnormal Matrix Remodeling of Advanced Atherosclerotic Plaques in Apolipoprotein E–Deficient Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[13]  Z. Galis,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[14]  A. Chiavegato,et al.  Contribution of Adventitial Fibroblasts to Neointima Formation and Vascular Remodeling: From Innocent Bystander to Active Participant , 2001, Circulation research.

[15]  A. Eddy,et al.  PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. , 2001, Kidney international.

[16]  R. Iozzo,et al.  Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. , 2001, The Journal of clinical investigation.

[17]  S. Weiss,et al.  Nitric oxide inhibition increases matrix metalloproteinase-9 expression by rat aortic smooth muscle cells in vitro. , 2001, Journal of vascular surgery.

[18]  H. Lijnen.  Plasmin and Matrix Metalloproteinases in Vascular Remodeling , 2001, Thrombosis and Haemostasis.

[19]  R. Strieter,et al.  Viral IL-10 Gene Transfer Decreases Inflammation and Cell Adhesion Molecule Expression in a Rat Model of Venous Thrombosis1 2 , 2000, The Journal of Immunology.

[20]  Tatsuo Tanaka,et al.  Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size , 1999, Cancer.

[21]  M. Burdick,et al.  Neovascularization during venous thrombosis organization: a preliminary study. , 1999, Journal of vascular surgery.

[22]  A. Singer,et al.  Cutaneous wound healing. , 1999, The New England journal of medicine.

[23]  A. Zalewski,et al.  Role of matrix metalloproteinases and their tissue inhibitors in the regulation of coronary cell migration. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[24]  F. Dignat-George,et al.  Evidence for the Expression of Urokinase-type Plasminogen Activator by Human Venous Endothelial Cells In Vivo , 1998, Thrombosis and Haemostasis.

[25]  L. Greenfield,et al.  IL-10 regulates thrombus-induced vein wall inflammation and thrombosis. , 1998, Journal of immunology.

[26]  M. Reidy,et al.  Expression of extracellular matrix proteins accompanies lesion growth in a model of intimal reinjury. , 1998, Circulation research.

[27]  M. Adams,et al.  Wound healing: a paradigm for lumen narrowing after arterial reconstruction. , 1998, Journal of vascular surgery.

[28]  D. Faxon,et al.  Collagen content is significantly lower in restenotic versus nonrestenotic vessels after balloon angioplasty in the atherosclerotic rabbit model. , 1997, Circulation.

[29]  H. Nagase.  Activation mechanisms of matrix metalloproteinases. , 1997, Biological chemistry.

[30]  D. Loskutoff,et al.  Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. , 1996, The Journal of clinical investigation.

[31]  A. Strongin,et al.  Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.

[32]  L. Greenfield,et al.  Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[33]  P. Libby,et al.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.

[34]  J. O'Connell,et al.  Regulation of Matrix Metalloproteinase Activity a , 1994, Annals of the New York Academy of Sciences.

[35]  R. Lawn,et al.  Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice , 1994, Nature.

[36]  P. Libby,et al.  Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. , 1994, Circulation research.

[37]  B. Lindblad,et al.  A prospective study of the incidence of deep‐vein thrombosis within a defined urban population , 1992, Journal of internal medicine.

[38]  S. Weiss.  Tissue destruction by neutrophils. , 1989, The New England journal of medicine.

[39]  J. Keller,et al.  Venous Thromboembolism and Other Venous Disease in the Tecumseh Community Health Study , 1973, Circulation.